Gene-expression analysis for prediction of RTS,S-induced protection in humans

References

• Plotkin SA. Vaccines: the fourth century. Clin. Vaccine Immunol.16(12), 1709–1719 (2009).
   PubMed Web of Science ®Google Scholar
• Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science271(5247), 324–328 (1996).
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Parida SK. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe4(3), 219–228 (2008).
   PubMedGoogle Scholar
• Frevert U. Sneaking in through the back entrance: the biology of malaria liver stages. Trends Parasitol.20(9), 417–424 (2004).
   Google Scholar
• Kwiatkowski D, Bate CA, Scragg IG et al. The malarial fever response – pathogenesis, polymorphism and prospects for intervention. Ann. Trop. Med. Parasitol.91(5), 533–542 (1997).
   Web of Science ®Google Scholar
• Snow RW, Trape JF, Marsh K. The past, present and future of childhood malaria mortality in Africa. Trends Parasitol.17(12), 593–597 (2001).
   PubMed Web of Science ®Google Scholar
• Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med.5(3), 340–343 (1999).
   PubMed Web of Science ®Google Scholar
• Plowe CV, Alonso P, Hoffman SL. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J. Infect. Dis.200(11), 1646–1649 (2009).
   PubMed Web of Science ®Google Scholar
• Alonso PL. Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind. Int. Microbiol.9(2), 83–93 (2006).
   Google Scholar
• Garcon N, Heppner DG, Cohen J. Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant. Expert Rev. Vaccines2(2), 231–238 (2003).
   PubMedGoogle Scholar
• Polhemus ME, Remich SA, Ogutu BR et al. Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS One4(7), e6465 (2009).
   PubMed Web of Science ®Google Scholar
• Alonso PL, Sacarlal J, Aponte JJ et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet364(9443), 1411–1420 (2004).
   PubMed Web of Science ®Google Scholar
• Moorthy VS, Ballou WR. Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar. J.8(1), 312 (2009).
   PubMed Web of Science ®Google Scholar
• Overstreet MG, Cockburn IA, Chen YC, Zavala F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’ immune response. Immunol. Rev.225, 272–283 (2008).
   PubMed Web of Science ®Google Scholar
• Hill AV. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat. Rev. Immunol.6(1), 21–32 (2006).
   PubMed Web of Science ®Google Scholar
• Pinder M, Reece WH, Plebanski M et al. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clin. Exp. Immunol.135(2), 286–293 (2004).
   PubMed Web of Science ®Google Scholar
• Kester KE, Cummings JF, Ofori-Anyinam O et al. Randomized, double-blind, Phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis.200(3), 337–346 (2009).
   PubMed Web of Science ®Google Scholar
• Kester KE, Cummings JF, Ockenhouse CF et al. Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine26(18), 2191–2202 (2008).
   PubMed Web of Science ®Google Scholar
• Stoute JA, Slaoui M, Heppner DG et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med.336(2), 86–91 (1997).
   PubMed Web of Science ®Google Scholar
• Bejon P, Andrews L, Andersen RF et al. Calculation of liver-to-blood inocula, parasite growth rates, and pre-erythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J. Infect. Dis.191(4), 619–626 (2005).
   PubMed Web of Science ®Google Scholar
• Vahey MT, Wang Z, Kester KE et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J. Infect. Dis.201(4), 580–589 (2010).
   PubMed Web of Science ®Google Scholar
• Rieckmann KH. Human immunization with attenuated sporozoites. Bull. World Health Organ.68(Suppl.), 13–16 (1990).
   PubMedGoogle Scholar
• Strehl B, Seifert U, Kruger E et al. Interferon-γ, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev.207, 19–30 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng Y. Toward an atomic model of the 26S proteasome. Curr. Opin. Struct. Biol.19(2), 203–208 (2009).
   Google Scholar
• Jacobsen M, Repsilber D, Gutschmidt A et al. Deconfounding microarray analysis – independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. Methods Inf. Med.45(5), 557–563 (2006).
   PubMedGoogle Scholar
• Repsilber D, Kern S, Telaar A et al. Biomarker discovery in heterogeneous tissue samples -taking the in-silicode-confounding approach. BMC Bioinformatics11, 27 (2010).
   Google Scholar
• Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol.9(10), 741–747 (2009).
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol.10(1), 116–125 (2009).
   PubMed Web of Science ®Google Scholar
• Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med.205(13), 3119–3131 (2008).
   PubMed Web of Science ®Google Scholar
• Zhu W, Higgs BW, Morehouse C et al. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children. Vaccine28(16), 2865–2876 (2010).
   PubMed Web of Science ®Google Scholar